Towards Healthcare
Gene Transfer Technologies Market to Progress USD 4.36 Billion in 2025

Gene Transfer Technologies Market 2025 Top Players, Trends & 2034 Projections Unveiled

Market insights predict, the gene transfer technologies industry is expected to grow from USD 3.98 billion in 2024 to USD 9.97 billion by 2034, driven by a CAGR of 9.62%. These techniques play a vital role in gene therapy, biotechnology research, and the development of genetically modified 

  • Insight Code: 5971
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The gene transfer technologies market size is calculated at USD 3.98 billion in 2024, grew to USD 4.36 billion in 2025, and is projected to hit around USD 9.97 billion by 2034, expanding at a CAGR of 9.62% during the forecast period from 2025 to 2034.

North America is leading the biological inactivated vaccine market due to strong government support for genomic research and a robust ecosystem of biotech firms and academic institutions.

The gene transfer therapy market includes five segments such as by delivery mode, end-user, by application, by vector type, and by mode of delivery.

Some key players include Thermo Fisher Scientific, Inc., Lonza Group AG, and Merck KGaA.

Key trends include government initiatives and mergers, and acquisitions

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.